Aarti Pharmalabs Stock Scales New 52-Week Peak at Rs 962: Key Reasons Behind the Surge
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Aarti Pharmalabs Share Price moved to Rs 951.3 on 25 September 2026, up Rs 16.85 or 1.8% from the previous close of Rs 934.45, after touching a fresh 52-week high of Rs 962. The company’s market capitalisation stood at Rs 8,524.81 crore, placing the move in a clear market-cap context for Aarti Pharmalabs Ltd. (AARTIPHARM). This Aarti Pharmalabs Share Price update is relevant because the day’s numbers confirm a new yearly high and a higher intraday range, while the supplied data does not establish any company-specific catalyst. For readers tracking Aarti Pharmalabs Share Price Today, the event is best understood through the verified price move, turnover of Rs 2.17 crore and the stock’s position versus its own 52-week range.
The latest Aarti Pharmalabs Stock News therefore centres on price action rather than a disclosed trigger. Univest is tracking the fresh 52-week high, the day’s range and the valuation context so that the move can be read alongside Aarti Pharmalabs Share Price Live data, market capitalisation and industry benchmarks.
Aarti Pharmalabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 951.3 |
| Previous Close | Rs 934.45 |
| Today's Move | +Rs 16.85 (+1.8%) |
| Open | Rs 933.95 |
| High | Rs 962 |
| Low | Rs 914.9 |
| Turnover | Rs 2.17 crore |
| Market Capitalisation | Rs 8,524.81 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 951.3 versus the previous close of Rs 934.45, a rise of 1.8%. The stock opened at Rs 933.95, reached a high of Rs 962 and touched a low of Rs 914.9.
Aarti Pharmalabs Share Price Today showed a firm upward move from the opening level of Rs 933.95 to a high of Rs 962 and a low of Rs 914.9. The stock closed the session at Rs 951.3, above the previous close of Rs 934.45, and finished Rs 16.85 higher on the day. Because the day’s high matched the fresh 52-week high of Rs 962, the session confirmed a new one-year high for Aarti Pharmalabs Share Price. The turnover of Rs 2.17 crore gives a factual measure of traded value for the session and helps frame the day’s price action without adding interpretation beyond the supplied numbers. In Aarti Pharmalabs Share News, the main takeaway is straightforward: the share moved to a yearly high and held most of the day’s gain into the close. That is the clearest fact pattern available in today’s Aarti Pharmalabs Stock News, and it naturally leads into the company’s valuation and financial backdrop.
Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,524.81 crore |
| P/E Ratio | 39.75x |
| P/B Ratio | 3.87x |
| ROE | 8.5% |
| ROCE | 10.77% |
| EPS | Rs 23.51 |
| Book Value Per Share | Rs 241.54 |
| Dividend Yield | 0.37% |
Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 39.75x, P/B 3.87x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.
Aarti Pharmalabs Ltd. has a market capitalisation of Rs 8524.81 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 39.75x, P/B at 3.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.49x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 39.75x |
| Benchmark Median P/E | 32.49x |
| Benchmark Average P/E | 49.64x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 3.87x |
| Benchmark Median P/B | 2.94x |
| Company ROE | 8.5% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 10.77% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 8,524.81 crore |
| Benchmark Median Market Cap | Rs 793.62 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 39.75x, which is above the benchmark median of 32.49x, a difference of +22.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.74%, a difference of -27.6%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.63%, a difference of -20.98%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Procter & Gamble Health Ltd. | PGHL | 9,002.84 | 25.23 | 14.62 | 62.18 | 84.86 |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR | 9,149.49 | 34.4 | 26.3 | 73.2 | 98.11 |
| Supriya Lifescience Ltd. | SUPRIYA | 7,746.07 | 39.05 | 6.34 | 19.06 | 25.3 |
| Innova Captab Ltd. | INNOVACAP | 7,435.52 | 47.44 | 6.53 | 13.75 | 15.04 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,410.7 | 53.55 | 5.92 | 12.11 | 17.4 |
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 39.75x compared with the displayed peer median of 39.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 19.06% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 25.3%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 8,524.81 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Aarti Pharmalabs
- Aarti Pharmalabs Share Price touched a fresh 52-week high of Rs 962 and closed at Rs 951.3.
- The session showed a gain of Rs 16.85, or 1.8%, versus the previous close of Rs 934.45.
- The stock’s market capitalisation stood at Rs 8,524.81 crore.
- Valuation data shows a P/E of 39.75 and a P/B of 3.87.
- ROE stood at 8.5% and ROCE at 10.77%, both below the industry medians in the supplied benchmark.
About Aarti Pharmalabs
Aarti Pharmalabs Ltd. is classified under the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is the key factual company context supplied for this Aarti Pharmalabs Share Price update. The stock is listed on NSE and BSE, and the latest Aarti Pharmalabs Stock News event is the fresh 52-week high recorded in today’s session. For readers scanning Aarti Pharmalabs Company News, the available profile is concise and centred on its sector placement, market capitalisation and financial ratios rather than a broader business description. Univest uses the company’s verified classification and market data to keep the note factual and searchable.
Track Aarti Pharmalabs Share Price on Univest
Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Aarti Pharmalabs Share Price on Univest for live price updates, 52-week levels, valuation ratios, market cap, shareholding pattern and company-level market insights. Univest also presents Aarti Pharmalabs Share Price Today alongside sector and peer context, so readers can follow the stock’s movement in one place. For ongoing Aarti Pharmalabs Share News, Univest keeps the analysis focused on verified data and clear market context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Aarti Pharmalabs Share Price today?
Ans. Aarti Pharmalabs Share Price was Rs 951.3 in the latest session, up 1.8% from the previous close of Rs 934.45. The stock also touched a fresh 52-week high of Rs 962 during the day.
Did Aarti Pharmalabs hit a fresh 52-week high?
Ans. Yes. Aarti Pharmalabs Share Price touched Rs 962, which is the fresh 52-week high in the supplied data. The closing price remained at Rs 951.3, keeping the day’s gain intact at the close.
Why is Aarti Pharmalabs Share Price in focus today?
Ans. Aarti Pharmalabs Share Price is in focus because it reached a new yearly high, gained Rs 16.85 on the day, and closed with a market capitalisation of Rs 8,524.81 crore.
What does Aarti Pharmalabs valuation look like?
Ans. The stock trades at a P/E of 39.75 and a P/B of 3.87. In the supplied industry benchmark, that places it above the median on both measures but below the peer-group averages.
How do Aarti Pharmalabs ROE and ROCE compare with the industry?
Ans. Aarti Pharmalabs reported ROE of 8.5% and ROCE of 10.77%. Both are below the industry medians of 11.74% for ROE and 13.63% for ROCE in the supplied benchmark. ROE stands at 8.5%.
What do EPS and book value show for Aarti Pharmalabs?
Ans. EPS is Rs 23.51 and book value per share is Rs 241.54. These two figures help frame earnings and accounting net worth behind each share, alongside the current Aarti Pharmalabs Share Price.
How does Aarti Pharmalabs compare with peers?
Ans. Compared with peers such as Procter & Gamble Health, Sanofi Consumer Healthcare India and Supriya Lifescience, Aarti Pharmalabs sits in the middle on valuation and market cap within the supplied list.
What is the dividend yield for Aarti Pharmalabs?
Ans. The supplied dividend yield is 0.37%. It is a historical or current payout measure, so it should be read as a factual ratio rather than a forecast of future distributions.
What sector does Aarti Pharmalabs belong to?
Ans. Aarti Pharmalabs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector context is important when reading Aarti Pharmalabs Share Price alongside the same-industry benchmark and peers.
Where can I track Aarti Pharmalabs Share Price on Univest?
Ans. Univest tracks Aarti Pharmalabs Share Price with live updates, 52-week levels, valuation ratios, peer context and market cap data. It is built to help readers follow the stock in one place.
